Lijun Zhu Selected Research

Lymphoma (Lymphomas)

6/2010	Bortezomib therapeutic effect is associated with expression and mutation of FGFR3 in human lymphoma cells.
5/2005	Fibroblast growth factor receptor 3 inhibition by short hairpin RNAs leads to apoptosis in multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lijun Zhu Research Topics

Disease

40	Neoplasms (Cancer) 03/2024 - 03/2006
14	Breast Neoplasms (Breast Cancer) 10/2023 - 04/2015
11	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2024 - 01/2021
10	Obesity 11/2023 - 01/2011
10	Stroke (Strokes) 11/2022 - 01/2013
8	Hypertension (High Blood Pressure) 10/2022 - 09/2017
7	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 04/2015
6	Carcinogenesis 01/2019 - 04/2012
5	Ischemic Stroke 01/2024 - 02/2013
5	Rheumatoid Arthritis 01/2022 - 01/2014
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2013
4	Carcinoma (Carcinomatosis) 01/2024 - 03/2006
4	Cardiotoxicity 09/2023 - 05/2011
4	Pain (Aches) 03/2023 - 10/2016
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2015
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2017 - 01/2017
3	Diarrhea 02/2024 - 01/2020
3	Infections 01/2024 - 10/2021
3	Inflammation (Inflammations) 11/2023 - 01/2022
3	Gestational Diabetes (Gestational Diabetes Mellitus) 08/2023 - 01/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 01/2022
3	Ischemia 07/2022 - 02/2002
3	Atherosclerosis 01/2020 - 10/2019
3	Genetic Predisposition to Disease (Genetic Predisposition) 11/2019 - 11/2017
3	Multiple Myeloma 01/2009 - 01/2005
2	Colonic Neoplasms (Colon Cancer) 03/2024 - 12/2022
2	COVID-19 01/2024 - 11/2021
2	Overweight 11/2023 - 06/2015
2	Poisoning 09/2023 - 04/2015
2	Insulin Resistance 08/2023 - 12/2022
2	Non-alcoholic Fatty Liver Disease 04/2023 - 01/2020
2	Edema (Dropsy) 03/2023 - 04/2018
2	Sepsis (Septicemia) 01/2023 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 12/2022 - 01/2022
2	Acute Coronary Syndrome 11/2022 - 01/2022
2	Body Weight (Weight, Body) 10/2022 - 06/2021
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2022 - 08/2015
2	Osteoarthritis 01/2022 - 01/2017
2	Critical Illness (Critically Ill) 09/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2016
2	Neural Tube Defects (Exencephaly) 11/2019 - 12/2018
2	Atherosclerotic Plaque (Atheroma) 11/2019 - 10/2019

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2005
9	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2014
9	EnzymesIBA 06/2021 - 07/2010
7	Therapeutic UsesIBA 11/2023 - 01/2009
6	Messenger RNA (mRNA)IBA 01/2021 - 01/2005
5	Interleukin-6 (Interleukin 6)IBA 11/2023 - 05/2014
5	Polysaccharides (Glycans)IBA 04/2023 - 01/2017
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2022 - 01/2021
5	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2019 - 03/2006
4	AlkaloidsIBA 09/2023 - 01/2014
4	Analgesics (Analgesic Drugs)IBA 03/2023 - 12/2020
4	CholesterolIBA 12/2022 - 12/2018
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
4	ORALIT (ORS)IBA 10/2021 - 09/2017
4	ATP-Binding Cassette Sub-Family B Member 4IBA 01/2020 - 01/2016
4	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 06/2010 - 01/2005
3	DNA (Deoxyribonucleic Acid)IBA 05/2024 - 01/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 02/2024 - 01/2020
3	RNA (Ribonucleic Acid)IBA 01/2024 - 10/2018
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2023 - 12/2022
3	Apolipoproteins E (ApoE)IBA 04/2023 - 10/2019
3	Simvastatin (Zocor)FDA LinkGeneric 12/2022 - 01/2021
3	Blood Glucose (Blood Sugar)IBA 11/2022 - 12/2018
3	LipidsIBA 10/2022 - 10/2019
3	Peptides (Polypeptides)IBA 01/2022 - 12/2006
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022 - 01/2021
3	PolymersIBA 11/2021 - 06/2021
3	Uric Acid (Urate)IBA 01/2021 - 02/2013
3	Folic Acid (Vitamin M)FDA LinkGeneric 11/2019 - 06/2013
3	Multidrug Resistance-Associated Protein 2IBA 01/2019 - 04/2015
3	GlucuronidesIBA 12/2018 - 01/2016
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2018 - 04/2015
3	hydroxide ionIBA 01/2018 - 01/2017
3	Bortezomib (Velcade)FDA Link 06/2010 - 03/2006
2	Phosphotransferases (Kinase)IBA 03/2024 - 01/2023
2	LipopolysaccharidesIBA 03/2023 - 01/2021
2	AlbuminsIBA 02/2023 - 01/2023
2	Liposomes (Liposome)IBA 01/2023 - 01/2022
2	IR 820IBA 12/2022 - 11/2021
2	kaempferolIBA 12/2022 - 12/2018
2	Rab geranylgeranyl transferase beta-subunitIBA 12/2022 - 01/2022
2	geranylgeraniolIBA 12/2022 - 01/2022
2	Lipoprotein(a)IBA 11/2022 - 01/2022
2	polydopamineIBA 09/2022 - 01/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 02/2016
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 12/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	dimethylethylsilylimidazoleIBA 01/2020 - 07/2018
2	Insulin-Like PeptidesIBA 01/2020 - 09/2017

Therapy/Procedure

18	Therapeutics 04/2024 - 11/2009
8	Precision Medicine 10/2023 - 01/2021
6	Drug Therapy (Chemotherapy) 10/2023 - 03/2006
6	Photothermal Therapy 10/2023 - 01/2021
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2023 - 01/2014
3	Lasers (Laser) 01/2023 - 01/2022
2	Photochemotherapy (Photodynamic Therapy) 01/2023 - 01/2023
2	Secondary Prevention 12/2022 - 11/2022
2	Transplantation 01/2022 - 06/2012